"Neoplasm Grading" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Methods which attempt to express in replicable terms the level of CELL DIFFERENTIATION in neoplasms as increasing ANAPLASIA correlates with the aggressiveness of the neoplasm.
Descriptor ID |
D060787
|
MeSH Number(s) |
E01.789.612
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Grading".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Grading".
This graph shows the total number of publications written about "Neoplasm Grading" by people in this website by year, and whether "Neoplasm Grading" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2009 | 0 | 1 | 1 |
2010 | 0 | 1 | 1 |
2011 | 0 | 7 | 7 |
2012 | 0 | 21 | 21 |
2013 | 1 | 19 | 20 |
2014 | 0 | 20 | 20 |
2015 | 1 | 26 | 27 |
2016 | 1 | 23 | 24 |
2017 | 2 | 19 | 21 |
2018 | 1 | 22 | 23 |
2019 | 4 | 14 | 18 |
2020 | 2 | 13 | 15 |
2021 | 0 | 8 | 8 |
2022 | 0 | 5 | 5 |
2023 | 0 | 9 | 9 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Grading" by people in Profiles.
-
A radiomics based method for prediction of prostate cancer Gleason score using enlarged region of interest. BMC Med Imaging. 2023 12 08; 23(1):205.
-
The influence of the "cancer" label on perceptions and management decisions for low-grade prostate cancer. J Natl Cancer Inst. 2023 11 08; 115(11):1364-1373.
-
Four-quadrant vector mapping of hybrid multidimensional MRI data for the diagnosis of prostate cancer. Med Phys. 2024 Mar; 51(3):2057-2065.
-
International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer. Working Group 2: Grading of Mixed Grade, Invasive Urothelial Carcinoma Including Histologic Subtypes and Divergent Differentiations, and Non-Urothelial Carcinomas. Am J Surg Pathol. 2024 Jan 01; 48(1):e11-e23.
-
The Significance of International Federation of Gynecology and Obstetrics Grading in Microsatellite Instability-High and POLE-Mutant Endometrioid Endometrial Carcinoma. Mod Pathol. 2023 09; 36(9):100234.
-
Characteristics of prostate cancer patients captured by facility-based versus geography-based cancer registries. Urol Oncol. 2023 07; 41(7):324.e1-324.e7.
-
Genomic Classifier Performance in Intermediate-Risk Prostate Cancer: Results From NRG Oncology/RTOG 0126 Randomized Phase 3 Trial. Int J Radiat Oncol Biol Phys. 2023 10 01; 117(2):370-377.
-
Point-Counterpoint: Grade Group 1 (Gleason Score 6) Prostate Cancer Should Be Renamed to Improve Public Health: Pathologists' Perspective. J Urol. 2023 07; 210(1):23-25.
-
Physician Perception of Grade Group 1 Prostate Cancer. Eur Urol Focus. 2023 11; 9(6):966-973.
-
Removing the Designation of Cancer from Grade Group 1 Disease Will Do More Good than Harm. Eur Urol. 2023 04; 83(4):304-306.